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Abstract
The assembly of a specific polymeric ubiquitin chain on a target
protein is a key event in the regulation of numerous cellular
processes. Yet, the mechanisms that govern the selective synthesis
of particular polyubiquitin signals remain enigmatic. The homolo-
gous ubiquitin-conjugating (E2) enzymes Ubc1 (budding yeast) and
Ube2K (mammals) exclusively generate polyubiquitin linked
through lysine 48 (K48). Uniquely among E2 enzymes, Ubc1 and
Ube2K harbor a ubiquitin-binding UBA domain with unknown
function. We found that this UBA domain preferentially interacts
with ubiquitin chains linked through lysine 63 (K63). Based on
structural modeling, in vitro ubiquitination experiments, and NMR
studies, we propose that the UBA domain aligns Ubc1 with K63-
linked polyubiquitin and facilitates the selective assembly of K48/
K63-branched ubiquitin conjugates. Genetic and proteomics exper-
iments link the activity of the UBA domain, and hence the forma-
tion of this unusual ubiquitin chain topology, to the maintenance
of cellular proteostasis.
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Introduction
Numerous processes in the eukaryotic cell rely on posttranslational
modifications (PTMs) with the 76 amino acid protein ubiquitin
(Ub). These PTMs regulate the half-life, cellular localization,
binding of interaction partners, and/or activity of client proteins
(Swatek & Komander, 2016). Due to the large number of enzymes
involved and the multiple combinations through which they contri-
bute to ubiquitin transfer, ubiquitination comprises a highly versa-
tile and dynamic PTM system. In many cases, ubiquitin itself is
ubiquitinated at any of its seven lysine residues or its N-terminus
causing the formation of polymeric chains (Swatek & Komander,
2016). Depending on the linkage type, these ubiquitin chains have
distinct properties and induce different biological outcomes. For
example, polyubiquitin linked through lysine 48, which is the most
abundant type in cells (Clague et al, 2015), typically targets client
proteins to the 26S proteasome for degradation (Hershko & Ciechan-
over, 1998). In contrast, the second most frequent type under most
conditions (Clague et al, 2015; Swatek & Komander, 2016)—K63-
linked polyubiquitin—facilitates the assembly of protein complexes
and therefore governs cellular processes such as DNA damage repair
(Spence et al, 1995; Liu et al, 2018), transcriptional activation
(Wang et al, 2001), innate immune responses (Gack et al, 2007),
endocytosis (Gulia et al, 2017), or protein trafficking (Lauwers et al,
2009). The combination of different linkage types into mixed or
branched polymers further expands the diversity of ubiquitin
signals. The study of such heterogeneous chains is technically chal-
lenging, and reports on their biological significance and on the enzy-
matic machinery involved in their generation are scarce (Emmerich
et al, 2013; Meyer & Rape, 2014; Wertz et al, 2015; Ohtake et al,
2016; Ohtake et al, 2018).
Modification of substrates with ubiquitin requires the coordi-
nated and sequential activity of ubiquitin-activating enzymes (E1),
ubiquitin-conjugating enzymes (E2), and ubiquitin ligases (E3).
While E3 ligases typically confer substrate specificity, E2 ubiquitin-
conjugating enzymes often determine the linkage type and spatial
organization of the ubiquitin signal (Stewart et al, 2016). Recently,
low-affinity interactions with the acceptor ubiquitin (UbA) mediated
by ubiquitin-binding domains (UBDs) or other ubiquitin-binding
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interfaces outside the catalytically active UBC domain of E2
enzymes have emerged as key regulatory factors for the efficient
assembly of ubiquitin chains (Wright et al, 2016; Watson et al,
2019). For example, the Cue1 protein recruits the K48-specific E2
enzyme Ubc7 to the tip of a ubiquitin chain through association
with the penultimate ubiquitin moiety and therefore facilitates the
elongation of K48-linked polyubiquitin (von Delbr€uck et al, 2016;
Kniss et al, 2018). Similarly, the formation of K63-linked chains by
Ubc13 relies on its cofactor Uev1a, which aligns the immediate UbA
molecule with the active site of Ubc13 (Pastushok et al, 2005; Brani-
gan et al, 2015).
Unlike other E2 enzymes, human Ube2K (E2-25K, HIP2) and its
yeast homologue Ubc1 harbor a ubiquitin-associated domain (UBA
domain), whose function has remained unclear. Ube2K has been
linked to Huntington’s disease (Kalchman et al, 1996; Pril et al,
2007), amyloid-b neurotoxicity (Song et al, 2003), and overcoming
radiation-induced cell cycle arrest (Hong et al, 2019). Ubc1, in turn,
is involved in protein turnover and essential for survival of yeast
cells deleted for UBC4 (Seufert et al, 1990). It was associated with
vesicle biogenesis (Shieh et al, 2001), resistance to proteotoxic
stress (Meena et al, 2011), transcription factor shuttling (Jiao et al,
2016), and protein quality control in the endoplasmic reticulum
(Friedlander, et al, 2000) and in the nucleus (Ibarra et al, 2016).
Furthermore, Ubc1 and Ubc4 were shown to act cooperatively in the
degradation of substrates of the anaphase-promoting complex
(APC/C; Rodrigo-Brenni & Morgan, 2007). Like other E2 enzymes,
Ubc1 and Ube2K contain a catalytic core domain (UBC domain) of
about 150 amino acids, which folds into a b-sheet of four antiparal-
lel b-strands flanked by four a-helices (Stewart et al, 2016). While
some E2 enzymes promiscuously conjugate ubiquitin to a wide
range of polypeptides (e.g., Ubc4, Ubc6; Stoll et al, 2011; Weber
et al, 2016), other E2 enzymes selectively target specific lysine resi-
dues within ubiquitin (e.g., Ubc7, Ubc13; Pastushok et al, 2005; von
Delbr€uck et al, 2016). Ubc1 and Ube2K exclusively target K48 in ubi-
quitin for discharge, which has been attributed to the interaction of
polar residues located around the active site in the UBC domain
with polar residues within the acceptor ubiquitin molecule (UbA;
Rodrigo-Brenni et al, 2010; Middleton & Day, 2015). Accordingly,
the UBA domain is dispensable for the selective synthesis of K48-
linked polyubiquitin (Rodrigo-Brenni & Morgan, 2007). The UBA
domain also does not associate with the donor ubiquitin molecule
(Merkley et al, 2005). Furthermore, conflicting data have been
reported about the contribution of the UBA domain to enzymatic
reactivity and processivity (Rodrigo-Brenni et al, 2010; Lee et al,
2018; Cook et al, 2020).
Here, we show that the UBA domain facilitates the formation of
K48/K63-branched ubiquitin chains by Ubc1 and Ube2K. We
present a structural model for the complex architecture underlying
the reaction and link this activity to the resistance to proteotoxic
stress in living cells. Our study corroborates the pivotal role of low-
affinity UbA binding sites for polyubiquitin chain formation and
emphasizes the biological importance of branched ubiquitin chains.
Results
An in silico model of Ubc1 and Ube2K in complex with ubiquitin
molecules provides a rationale for the selective assembly of K48/
K63-branched ubiquitin chains
Initially, we hypothesized that the UBA domain facilitates the elon-
gation of K48-linked ubiquitin chains by Ubc1 in a similar manner
to the E2 enzyme Ubc7 and its cofactor Cue1. Therefore, we
expected that Ubc1 preferentially interacts with K48-linked poly-
ubiquitin. However, GST epitope-tagged full-length Ubc1 or its UBA
domain alone showed stronger binding to K63-linked ubiquitin
chains than to K48-linked ubiquitin chains in a semi-quantitative
binding experiment using fluorescently labeled ubiquitin (Fig 1A,
Appendix Fig S1). Both chain types interacted efficiently with the
UBA domain of Dsk2, which displays no preferences for the binding
of different ubiquitin chains (Raasi et al, 2005). The UBC domain of
Ubc1 alone (Ubc1-DUBA) or the ubiquitin-binding-deficient Ubc1-
LRV variant (aa179-181 QGF to LRV; Wilson et al, 2009) only bound
similar amounts of polyubiquitin as the GST protein, which was
used as a negative control. These findings indicated that K63-linked
polyubiquitin is the preferred substrate of Ubc1.
To understand how Ubc1 interacts with acceptor ubiquitin
(UbA), we aggregated published structural data on the Ubc1 homo-
logue Ube2K (Wilson et al, 2009; Ko et al, 2010; Middleton & Day,
2015; Lee et al, 2018) and combined them into an in silico model of
the E2 enzyme in complex with two ubiquitin molecules (Fig 1B).
Our structure prediction incorporates three previously reported
▸Figure 1. In silicomodel of Ubc1/Ube2K in complex with ubiquitin (Ub) provides a rationale for selective targeting of K63-linked ubiquitin chains resulting inthe assembly of K48/K63-branched chains.
A Binding of ubiquitin chains to immobilized GST-fusion proteins. Indicated proteins were purified from E. coli and incubated with equal amounts of preformed
fluorescently labeled ubiquitin chains, which were either K48- or K63-linked. The fraction of ubiquitin chains interacting with the bait protein was analyzed by
SDS–PAGE and fluorescence scan. Total fluorescence was quantified per lane and normalized to the first lane (rel. fluo.). Asterisk (*) indicates lane from the same
gel that was cropped and moved.
B A structural model of Ube2K in complex with two ubiquitin molecules was created based on previously published data (Ko et al, 2010; Middleton & Day, 2015). The
UBC domain associates via its active site cysteine with the side chain of K48 in the immediate acceptor ubiquitin molecule (UbA-prox). A second ubiquitin molecule
(UbA-dist) binds the UBA domain through the conserved hydrophobic patch. Selected atoms were highlighted as spheres: C-atom in the carboxy group (CC) of
UbA-prox-G76, S-atom in E2 active site Cys, CC in UbA-dist-L71, N-atoms (blue) in UbA-prox of e-amino groups of lysine residues (Ne) and in the backbone of M1
(Na).
C–E A structure of Ubc1 was superimposed onto the model from (B). Key residues were highlighted as sticks for the binding interfaces (C) between the UBC domain and
UbA-prox, (D) between the UBA domain and UbA-dist, and (E) between the UBC domain and UBA domain. Additionally, amino acids whose side chains contribute to
the UBC/UBA binding interface were determined and classified into “hot spot” or “contributing” residues using the algorithm SpotOn (Melo et al, 2016; Moreira
et al, 2017).
F Interatomic distances from L71-CC in UbA-dist to G76-CC in UbA-dist or to putative attachment sites in UbA-prox were measured for various known ubiquitin
conformations. The six closest attachment sites are listed in ascending order.
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binding interfaces: Ub/UBC domain (Fig 1C), Ub/UBA domain
(Fig 1D), and UBA domain/UBC domain (Fig 1E). While the model
was derived from X-ray crystallographic data of Ube2K, we superim-
posed a structure of Ubc1 (PDB: 1TTE) onto the final assembly
(Fig 1C–E). The interaction of the UBC domain with the immediate
acceptor ubiquitin (Fig 1C) was previously shown by HADDOCK
modeling (Middleton & Day, 2015). Extensive mutagenesis studies
in combination with activity assays validated the importance of the
reported side chain interactions for the transfer of ubiquitin (Middle-
ton & Day, 2015). In crystal structures of Ube2K in complex with u-
biquitin (PDB: 6IF1, 3K9P), the binding of ubiquitin by the UBA
domain involves the hydrophobic patch in ubiquitin and the helices
a1 and a3 in the UBA domain (Fig 1D). The UBA domains of other
proteins comprise equivalent binding interfaces with ubiquitin
(Kozlov et al, 2007; Michielssens et al, 2014). Crystal structures of
Ube2K (PDB: 5DFL, 6IF1, 3E46, 3F92, 3K9P) consistently show an
interaction between the UBA domain and the UBC domain. We used
the Phyre2 software (Kelley et al, 2015) to align the UBA and UBC
domains of Ubc1 with this interface and the program SpotOn (Melo
et al, 2016; Moreira et al, 2017) to assess the contribution of individ-
ual amino acid residues (Fig 1E).
In our analysis of the structural model, we observed that the C-
terminus of ubiquitin bound to the UBA domain (UbA-dist) projected
toward the ubiquitin molecule interacting with the UBC domain
(UbA-prox), while the C-terminus of UbA-prox pointed away from
UbA-dist (Fig 1B). The relative orientation of the two ubiquitin
monomers implied that Ube2K could engage a diubiquitin molecule
through simultaneous association of the UBC and UBA domains
with the proximal and distal ubiquitin moieties, respectively. We
hypothesized that such an architecture would facilitate the nucle-
ophilic attack of the UbA-prox K48 side chain on the UBC
~Ub thio-
ester resulting in the formation of a branched ubiquitin polymer.
To assess which types of ubiquitin chains could be accommo-
dated as the acceptor, we analyzed selected interatomic distances
within the model (Fig 1F). The covalent bond that connects the two
ubiquitin moieties of a diubiquitin molecule positions the carboxy
C-atom (CC) of UbA-dist G76 within 1.3 Å of the target N-atom in
UbA-prox. Importantly, ubiquitin contains a highly flexible C-termi-
nal region from L71 to G76 (Lange et al, 2008) and the dynamic
rotameric states of the attachment sites need to be considered, too.
To account for this, we first determined the distance between
L71-CC and G76-CC to be within 6.4 - 16.3 Å in an NMR ensemble
of 116 ubiquitin structures (PDB: 2K39). Next, we measured within
our model the distance from L71-CC of UbA-dist to various N-atoms
of lysine e-amino groups (Ne) in UbA-prox for the 25 most frequent
Lys rotamers (Shapovalov & Dunbrack, 2011), as well as to the
amino-terminal N-atom located in M1. Only K63-Ne in UbA-prox
was sufficiently close (14.4 Å) to allow a covalent link between
UbA-prox and UbA-dist. This finding further implicates K63-linked
chains as a preferred substrate for Ubc1. M1-Na—the next closest
attachment site—was located at a distance of 23.1 Å.
The UBA domain facilitates the turnover of K63-linked ubiquitin
and promotes the assembly of K48/K63-branched chains
To verify our structural model, we compared the enzymatic activity
of Ubc1 toward various acceptor ubiquitin molecules. To this end,
we monitored the transfer of fluorescently labeled monoubiquitin to
excess amounts of C-terminally blocked acceptor ubiquitin (Fig 2A).
Such single turnover ubiquitination experiments allowed us to
follow the formation of a defined reaction product (Fig 2B). The
relative fluorescence of this species was quantified and plotted over
time to determine the reaction kinetics (Fig 2C). Using a linear fit,
we obtained initial reaction rates for full-length Ubc1 or Ubc1-DUBA
against a panel of acceptor ubiquitin molecules (Fig 2D,
Appendix Fig S2). Ubc1 rapidly modified preformed K63-linked diu-
biquitin (K63-Ub2), but not monoubiquitin or K48-Ub2. The high
initial reaction rate with K63-Ub2 was dependent on the UBA
domain and was not observed in samples containing Ubc1-DUBA
(Fig 2D).
We then analyzed processing of K63-Ub2 variants that had lysine
48 replaced by arginine (K48R) in either the distal, the proximal, or
in both ubiquitin moieties. These substitutions remove the residue
targeted for ubiquitination by Ubc1 in the corresponding ubiquitin
molecule. Blocking this acceptor site in the proximal ubiquitin unit
strongly impaired ubiquitin attachment by Ubc1, while the replace-
ment of K48 in the distal moiety only had a minor impact (Fig 2D).
This observation suggests that the UBA domain aligns Ubc1 with
K63-Ub2 in a directional manner. Next, we employed K63-Ub2 with
arginine 42 replaced by alanine (R42A) in either one or both ubiqui-
tin molecules, which disrupts the binding to the UBA domain. While
the introduction of R42A into the proximal ubiquitin had no effect
on ubiquitination by Ubc1, the R42A exchange in the distal moiety
strongly disrupted enzymatic turnover (Fig 2D). These data imply
that the UBA domain binds the distal moiety in K63-Ub2 to align the
UBC domain with the proximal ubiquitin and therefore promotes
the formation of K48/K63-branched ubiquitin molecules (Fig 2E).
The association of the UBC and the UBA domain facilitates
formation of K48/K63-branched Ub chains
Our model predicts that the orientation of the UBA domain toward
the UBC domain is a crucial determinant for the overall architecture
of the Ubc1/UbA complex. However, the 17 amino acid stretch that
connects these regions is a highly dynamic structure (Merkley &
Shaw, 2004; Cook et al, 2015). Thus, we set out to identify defining
features of the putative UBC/UBA binding interface and analyze
their contribution to the activity of the enzyme. Sequence alignment
with other E2 enzymes (Fig 3A) revealed that the residues W144
and Y76 in the UBC domain, which are predicted to be central
constituents of the interaction interface (Fig 1E), are highly
conserved. Therefore, these amino acids most likely contribute to
the general E2 enzyme fold. However, at the positions correspond-
ing to L143 and L147 in Ubc1, which according to our model also
contribute to the hydrophobic UBC/UBA interface (Fig 1E), other E2
enzymes expose charged residues (Fig 3A). We therefore expressed
and purified Ubc1 variants that contained glutamic acid at these
sites and analyzed them with in vitro ubiquitination assays.
In agreement with our model, Ubc1(L143E) displayed reduced
activity toward the K63-Ub2 acceptor molecule (Fig 3B). In contrast,
introduction of the L147E replacement did not diminish substrate
processing. L147 is located at the fringe of the interface, and there-
fore, alterations of this site may cause only minor defects. The
combination of the L143E and L147E substitutions had an additive
effect on the activity of Ubc1 toward K63-Ub2. Possibly, interactions
between the side chains of the introduced glutamic acids resulted in
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a more profound disruption of the hydrophobic interface. With
monoubiquitin as the acceptor, we observed an equally low turn-
over for all tested Ubc1 variants (Fig 3B). This indicates that substi-
tution of the leucine residues and the consequential changes in the
relative positioning of the UBA and the UBC domains predominantly
affect the K48/K63-branching activity of the enzyme.
The region, which connects the UBC and the UBA domain, is
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Figure 2. Enzymatic activity assays show the preferential targeting of K63-linked ubiquitin chains by Ubc1 resulting in the assembly of K48/K63-branched
polyubiquitin.
A Reaction scheme for single turnover ubiquitination experiments with Ubc1 in the presence of fluorescently labeled monoubiquitin as donor and various C-terminally
blocked acceptor ubiquitin molecules.
B At indicated time points, samples were taken from the reaction mix and analyzed by SDS–PAGE and fluorescence scan. Product fluorescence over total fluorescence
per lane was quantified (rel. fluo.).
C The relative fluorescence was plotted over time for reactions with different ubiquitin acceptor molecules—for example in the presence of K63-linked diubiquitin
(K63-Ub2) or K48-linked diubiquitin. Initial reaction rates were determined as the slope of a linear fit of the fluorescence increase over 20 min.
D Initial reaction rates were determined for a panel of acceptor ubiquitin molecules in reactions with either full-length Ubc1 or Ubc1-DUBA (aa1-150). The binding of
the UBA domain to individual ubiquitin molecules was disrupted by introducing an R42A amino acid exchange in ubiquitin, while acceptor sites were blocked by
introducing the K48R substitution. Reactions were performed in triplicate. Bars show mean and SEM. For representative scans, see Appendix Fig S2.
E Schematic transition state for the reaction of Ubc1 with K63-linked diubiquitin. Binding of the distal moiety in K63-Ub2 to the UBA domain involves R42 in ubiquitin
and enhances targeting of K48 in the proximal moiety for discharge of donor ubiquitin by the UBC domain. This results in the assembly of a K48/K63-branched chain.
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(aa154-159). Yet, the association of the UBC domain with the UBA
domain places both ends of the linker in close proximity on the
same side of the complex (Fig 1B). We therefore hypothesized that
shortening of the linker should not affect the formation of the UBC/
UBA interface and accordingly should also not interfere with the
turnover of K63-Ub2. Thus, we generated Ubc1 variants lacking
stretches of five amino acids (aa152-156, aa157-161, aa162-166) or
combinations thereof and analyzed their ability to ubiquitinate K63-
Ub2. Consistent with the model, removal of any five or the last ten
amino acids (aa157-166) did not reduce product formation (Fig 3C).
Deletion of the complete linker region or of the amino acids 152-161
impaired the reaction to some extent, but these Ubc1 variants were
still significantly more active toward K63-Ub2 than Ubc1-DUBA.
Product formation with acceptor monoubiquitin was unchanged for
the linker deletion variants implying that the overall catalytic activ-
ity of Ubc1 was not disturbed.
The association of the UBC and the UBA domain creates a bind-
ing interface, which restricts the possible conformations of a diubi-
quitin molecule that engages both domains at the same time. This
limitation provides an attractive explanation for the selective target-
ing of K63-linked chains by Ubc1. To gain further insights into the
substrate specificity of the enzyme, we investigated the turnover of
UBC1_YEAST 70 QFDTKVYHPNISSVTGAI LDILKNAWSPVIT 100
UBC4_YEAST 69 SFTTKIYHPNINA-NGNI LDILKDQWSPALT 99
UBC5_YEAST 69 NFTTKIYHPNINS-SGNI LDILKDQWSPALT 99
UBC13_YEAST 70 RFLTKIYHPNIDR-LGRI LDVLKTNWSPALQ 100
104
UBC1_YEAST 120 DPQDAEVAQHYLRDRESFNKTAAL RLYAS 150
UBC4_YEAST 118 DPLVPEIAHIYKTDRPKYEATARE KKYAV 148
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Figure 3. Branched chain formation by Ubc1 relies on the association of the UBA domain with the UBC domain and is selective for K63-linked chains.
A Residues associated with the binding of the UBA domain to the UBC domain were analyzed through sequence alignment of Ubc1 with other E2 enzymes from S.
cerevisiae. Y76 and W144 in Ubc1 were predicted to be hot spot residues of the interface, while L143 and L147 were classified as contributing amino acids (Fig 1E).
B L143E and/or L147E amino acid substitutions were introduced into Ubc1 to disrupt the hydrophobic UBC/UBA domain interface. Single turnover ubiquitination
experiments were performed with these Ubc1 variants in the presence of K63-Ub2 with Ub(K48R) at the distal position or monoubiquitin as acceptor. Experiment and
initial rate determination as described in Fig 2.
C Ubc1 variants were generated with deletions in the linker region (aa152-167), which connects the UBA domain and the UBC domain. Single turnover ubiquitination
reaction mixes were incubated for 5 min with K63-Ub2 or for 20 min with monoubiquitin as acceptor. Final product formation was analyzed by SDS–PAGE and
fluorescence scan. Product fluorescence over total fluorescence (rel. fluo.) was quantified.
D C-terminally blocked M1-linked diubiquitin with or without a K48R amino acid substitution at the distal or proximal position was employed in single turnover
experiments with full-length Ubc1 or Ubc1-DUBA. Reactions with acceptor K63-Ub2 were carried out as controls. Initial rate determination as described in Fig 2.
Data information: All reactions were performed in triplicate. Bars show mean and SEM. For representative scans for the experiments shown in panels (B-D), see
Appendix Fig S3A–C.
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linear ubiquitin chains by Ubc1 with an in vitro ubiquitination assay
(Fig 3D). In these molecules, the carboxy-terminal glycine (G76) of
ubiquitin is attached to the amino-terminal methionine (M1) of the
next ubiquitin moiety. Linear polyubiquitin adopts so-called open
conformations that are highly similar to those of K63-linked chains
(Wang et al, 2014). Moreover, after K63, M1 is the second closest
attachment site to connect UbA-prox and UbA-dist in our model of a
diubiquitin molecule bound to Ubc1 (Fig 1F). Compared with the
processing of K63-Ub2, we measured approximately three times
lower initial reaction rates of Ubc1 in the presence of M1-Ub2 as an
acceptor (Fig 3D). Interestingly, a significantly higher initial reaction
rate was observed for M1-Ub2 containing Ub(K48R) at the distal
rather than at the proximal position. This mirrors the preference of
Ubc1 to discharge ubiquitin onto the proximal moiety of K63-Ub2.
In summary, M1-linked polyubiquitin can also serve as an acceptor
for branched chain synthesis by Ubc1 in vitro, but it represents a
poor substrate compared with K63-linked chains.
To further investigate the contribution of the UBA domain to the
enzymatic properties of Ubc1, we created variants of this enzyme
harboring different ubiquitin-binding domains. To this end, we
replaced the UBA domain with either the CUE domain of Cue1,
which specifically associates with K48-linked chains, or the Dsk2
UBA domain, which displays no preference but higher affinity for
the binding of different polyubiquitin molecules (Fig EV1A). We
tested these chimeric constructs in endpoint experiments employing
different acceptor ubiquitin molecules (Fig EV1B). No substitution
significantly increased total product formation. This supports the
idea of an intricate role of the UBA domain in enzyme activation
beyond merely increasing the local concentration of UbA at the UBC
domain of Ubc1.
Characterization of UBA domain binding to differently linked
polyubiquitin by NMR spectroscopy
The CUE domain of Cue1 preferentially associates with the proximal
moieties in K48-linked chains, which facilitates chain elongation by
Ubc7 (von Delbr€uck et al, 2016). Based on the results of the activity
assays with Ubc1, we speculated that the UBA domain in Ubc1 also
exhibits distinctive ubiquitin-binding properties. To investigate this
in more detail, we synthesized K48-Ub2 and K63-Ub2 containing
15N-labeled moieties at either the proximal or the distal position.
Upon titration with unlabeled UBA domain, binding events at those
positions were analyzed by NMR spectroscopy (Fig 4A–D). The
strongest chemical shift perturbations (CSPs) were recorded for
amino acids within the hydrophobic patch of ubiquitin (I44, L8,
G47, V70, R42, H68). Interestingly, we also observed a pronounced
CSP of K48 in ubiquitin indicating that this residue contributes to
binding of the UBA domain. As shown for other systems, such an
interaction can compete with the enzymatic activity of UBC domains
(Kniss et al, 2018). By employing a model based on two different
binding sites in diubiquitin (Raasi et al, 2005), we quantitatively
analyzed the NMR titration experiments and calculated KD values
(Fig 4E and F). For the binding of the UBA domain to monoubiqui-
tin, a previous study reported a KD value of (228  68 µM; Merkley
& Shaw, 2004). We determined comparable KD values of
(188  20 µM) and (192  13 µM) for the proximal and distal
moiety in K63-Ub2, respectively. Compared with K63-Ub2, the bind-
ing affinity for the distal moiety in K48-Ub2 was equal within error
(259  58 µM) but lower for the proximal moiety (382  98 µM).
This may be explained by the involvement of the Ub K48 side chain
in establishing the Ub/UBA interaction, which is blocked in all but
the most distal moiety of a K48-linked chain. The reduced affinity
toward K48-linked polyubiquitin and the role of Ub K48 in the bind-
ing interface challenge a selective function of Ubc1 in the formation
of homotypic K48-linked ubiquitin chains.
The distinct ubiquitin-binding properties of the Cue1 CUE
domain and the Ubc1 UBA domain may also be explained by the dif-
ferent requirements for ubiquitin chain elongation and branched
chain formation, respectively. Chain elongation involves the itera-
tive interaction of the E2 enzyme with the most distal ubiquitin
moiety. However, the relative abundance of this ubiquitin molecule
decreases proportionally with the length of the ubiquitin chain, and
in consequence, productive binding events become increasingly
unlikely. Selective binding to a particular ubiquitin moiety as
described for the CUE domain in Cue1 and the subsequent recruit-
ment of the cognate E2 enzyme Ubc7 to the tip of a ubiquitin chain
can compensate this effect (von Delbr€uck et al, 2016). In contrast,
the introduction of a branching point can occur at any proximal ubi-
quitin molecule in the chain. Therefore, the number of possible
attachment sites and thus the chance for productive binding events
increase with the length of the polymer. This renders the binding to
a specific position less important for branching.
Branched chain assembly by Ubc1 is conserved among species
and outperforms de novo chain synthesis
To further explore the enzymatic properties of Ubc1 and its homo-
logues Ube2K (human) and ubc-20 (C. elegans), we performed
single turnover ubiquitination experiments and directly compared
the activity of these enzymes with the bona fide chain building E2
enzymes Ubc7 and Ubc13 (Fig 5A–C). Ubc7/Cue1 displayed overall
higher activity than Ubc1 in these assays. For example, the elonga-
tion of K48-Ub2 by Ubc7/Cue1 was approximately 50 times faster
than by equimolar amounts of Ubc1. However, the modification of
K63-Ub2 occurred only with two times higher rates. Moreover, Ubc1
showed eleven times higher initial reaction rates for its preferred
substrate (K63-Ub2) over the best off-target molecule (monoubiqui-
tin), while Ubc7 only showed a twofold higher rate (K48-Ub2 versus
K63-Ub2). These observations emphasize the high selectivity of
Ubc1 for the processing of K63-Ub2. Similar to Ubc1, Ube2K and
ubc-20 displayed significantly higher initial reaction rates for
K63-Ub2 with Ub(K48R) at the distal rather than at the proximal
position. In contrast, Ubc13/Uev1a modified both acceptor mole-
cules equally fast. This indicates that the presented mechanism for
K48/K63-branched chain formation is conserved among species.
Ultimately, we aimed to assess the ability of Ubc1 to form ubiqui-
tin chains de novo and to compare it with its propensity to generate
branched polyubiquitin (Fig 6A). In an in vitro ubiquitination assay
with fluorescently labeled monoubiquitin as the only ubiquitin entity,
Ubc1 mainly synthesized diubiquitin and to a lesser extent higher
molecular weight products over time (Fig 6B). We did not observe a
stepwise increase in the size of the products, and thus, we assume
that at least some of the larger species arose from the en bloc transfer
of smaller chains or represent ubiquitinated forms of the enzymes in
the reaction. The overall fluorescence intensity of the products
synthesized by Ubc1-DUBA was similar to that generated by full-
ª 2021 The Authors The EMBO Journal 40: e106094 | 2021 7 of 19
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Figure 4. Interaction analysis of individual ubiquitin moieties in K48-Ub2 or K63-Ub2 with the UBA domain of Ubc1.
A–D 15N-labeled diubiquitin probes were titrated with the UBA domain up to molar ratio of 8:1 (UBA : Ub2). NMR spectra were recorded for (A) the distal moiety in
K63-Ub2, (B) the proximal moiety in K63-Ub2, (C) the distal moiety in K48-Ub2, or (D) the proximal moiety in K48-Ub2.
E CSPs of I44 were plotted over UBA domain concentration.
F KD values for binding of the UBA domain were determined from results in (E) assuming two independent but different binding sites.
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length Ubc1. However, in reactions containing Ubc1-DUBA we
detected larger amounts of high molecular weight ubiquitin conju-
gates (Fig EV2A). Full-length Ubc1 may be less capable to produce
such species, because the discharge of preformed ubiquitin chains en
bloc is less efficient due to their interaction with the UBA domain
(Cook et al, 2020). Next, we set up reactions containing Alexa
488-labeled ubiquitin and a threefold lower concentration of Alexa
647-labeled K63-linked Ub3 as an acceptor molecule (Fig 6C). In
consequence, both molecules contributed to equimolar amounts of u-
biquitin moieties in these assays. By overlaying scans of both fluores-
cence channels, we compared the capabilities of full-length Ubc1 and
Ubc1-DUBA to modify K63-Ub3 or to synthesize polyubiquitin de
novo. While Ubc1-DUBA targeted both ubiquitin species with almost
equal efficiency, the full-length enzyme formed significantly more
product with the K63-Ub3 acceptor. This indicates that the UBA
domain increases the likelihood for productive binding of Ubc1 to the
K63-Ub3 acceptor, which is in line with our model for branched chain
synthesis. We speculate that with sufficiently high substrate concen-
trations, branched chain formation should significantly outcompete
de novo chain formation by Ubc1. However, such an experiment is
not feasible due the relatively high Km value of the enzyme (473 µM
for Ube2K; Middleton & Day, 2015).
In an approximation, we performed endpoint analyses of reac-
tions in the presence or absence of K63-linked Ub4 as an acceptor at
a 1:4 molar ratio to fluorescently labeled donor ubiquitin (Fig 6D).
For de novo chain formation with only fluorescent monoubiquitin,
we again observed more high molecular weight product formation
by Ubc1-DUBA than by full-length Ubc1 (lane 1). These reaction
products were resistant to treatment with the K63-specific deubiqui-
tinating enzyme AMSH (lane 4). To determine the product pattern
resulting from modification of K63-Ub4, we employed methylated
ubiquitin, which can serve only as donor in the reaction (lane 2). As
expected, significantly more product was formed by full-length Ubc1
than by Ubc1-DUBA. Moreover, prominent signals for one to three
times modified K63-Ub4 could be observed, while the UBC domain
alone mostly transferred one and to a lesser extent two moieties.
Upon AMSH treatment, the reaction products were shortened to diu-
biquitin indicative of multiple monoubiquitination of the K63-linked
chain (lane 5). Combining unmethylated donor ubiquitin and the
K63-Ub4 acceptor in a reaction with Ubc1-DUBA (lane 3) resulted in
a product pattern closely resembling an overlay of the control reac-
tions (lane 1 and 2). In contrast, the product pattern for full-length
Ubc1 (lane 3) mostly resembled the modification of K63-Ub4 and
showed reduced formation of Ub2 and of high molecular weight
K48-linked chains. AMSH treatment yielded mostly diubiquitin
showing that Ubc1 predominantly introduces multiple branching
points into the K63-linked chain instead of extending K48-linked
chains from the K63-linked chain as scaffold (lane 6). In summary,
these results demonstrate a preference for branching over proces-
sive chain assembly by Ubc1.
Specific cellular functions of Ubc1 require the UBA domain
To evaluate the biological significance of our findings, we aimed to
verify the formation of K48/K63-branched chains in S. cerevisiae.
Mass spectrometric detection of such ubiquitin species is enabled by
the substitution of R54 in ubiquitin with alanine (Ohtake et al,
2016), which removes a trypsin cleavage site (Fig EV3A). We
prepared a reference peptide and a spectral library accordingly (Fig
EV3B and C). Ultimately, we detected the distinct marker peptide in
lysates of yeast cells expressing Ub(R54A) but not in a control strain
expressing Ub(R54A,K63R; Fig EV3D).
We next replaced the endogenous UBC1 gene in yeast with a



































































Figure 5. Branched chain formation by Ubc1 is conserved among species. Ubc1 is slower but more selective than bona fide chain building E2 enzymes.
A The activity of Ubc1 was compared with the K48-linked chain building enzyme Ubc7/Cue1 in single turnover ubiquitination experiments in the presence of either
monoubiquitin, K48-Ub2, or K63-Ub2. Initial rates were determined as described in Fig 2.
B The K63-linked chain building enzyme Ubc13 with its cofactor Uev1a or the Ubc1 homologue Ube2K (h. sapiens) was employed in single turnover ubiquitination
experiments in the presence of K63-Ub2 with Ub(K48R) at the proximal or distal position or in the presence of K48-Ub2. Initial rate determination as described in
Fig 2.
C Experiment as in (B) but with the Ubc1 homologue ubc-20 (C. elegans).
Data information: All reactions were performed in triplicate. Bars show mean and SEM. For representative scans of gels from the experiments shown here, see
Appendix Fig S3D and E.
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Figure 6. Branched chain formation by Ubc1 outperforms its capacity for de novo chain synthesis.
A Cartoon representation of reaction conditions used in (B–D), which simultaneously enable de novo chain assembly and the formation of K48/K63-branched chains.
B In vitro ubiquitination reactions with full-length Ubc1 or Ubc1-DUBA were performed. Samples were taken at indicated time points and analyzed by SDS–PAGE and
fluorescence scan. Free chain synthesis from Alexa 488-labeled monoubiquitin was observed over time. Fluorescence of all reaction products was quantified and
normalized to number of fluorophores per product (“de novo”). Double cross (‡) indicates ubiquitinated E2 enzyme.
C Reactions as in (B) were performed in the presence of C-terminally capped and Alexa 647-labeled K63-linked Ub3. Monoubiquitin and K63-Ub3 were used in a 3:1
molar ratio. Analysis as in (B). Modification of K63-Ub3 was identified through correlation of fluorescence channels and their fluorescence quantified in the 488
channel (“branched”). The image from the 647 channel was cropped below the point indicated by “647” (see Fig EV2).
D Alexa 488-labeled monoubiquitin and C-terminally capped K63-Ub4 were used in a 4:1 molar ratio for in vitro ubiquitination reactions with full-length Ubc1 or Ubc1-
DUBA. Where indicated, Alexa 488-labeled monoubiquitin was methylated prior to the reaction (met-Ub) to block de novo chain assembly. Reactions were incubated
overnight and quenched, and half the reaction mix from each condition was treated with the K63-specific deubiquitinating enzyme AMSH (lanes 4-6). Samples were
analyzed by SDS–PAGE and fluorescence scan.
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contains alanine resulting in an impaired binding of K63-linked ubi-
quitin chains (Fig EV4A and B). Accordingly, Ubc1-EA displays a
threefold reduction in reaction rate in the presence of K63-Ub2 in
single turnover experiments (Fig EV4C). Ubc1-EA is a stable protein
when expressed from the endogenous promoter (Fig EV4D) unlike
other investigated binding-deficient variants (Fig EV4E) or truncated
variants of Ubc1 (data not shown). We then determined the relative
abundance of K48-/K63-branched ubiquitin chains in wild-type
versus Dubc1 or UBC1-EA yeast cells by overexpression of 10xHis-
Ub(R54A) from a plasmid and enrichment of ubiquitinated material
from cell lysates by metal affinity chromatography (Fig 7A). We
performed proteomics experiments using SILAC technology in order
to obtain precise relative peptide-level fold changes (Ong et al,
2002). Peptides that exclusively originate from the K48-/K63-
branched ubiquitin species were substantially less abundant in
samples obtained from Dubc1 cells compared with those from the
wild-type background (Figs 7B and EV4F). It must be noted that the
amount of other ubiquitin-derived peptides was also reduced albeit
to a lesser extent. The overall perturbation of the ubiquitome land-
scape might be caused by a disruption of the pleiotropic functions
associated with Ubc1. We did not detect significant differences in
the quantity of any ubiquitin marker peptide in the lysates of cells
harboring UBC1-EA when compared to wild type (Figs 7C and
EV4F). Expression of Ubc1-EA does not cause a shift in total cellular
ubiquitin, possibly because branched chain assembly by Ubc1 is
triggered in response to specific stimuli or only affects a small
number of substrates. The reduced reaction rate of Ubc1-EA with
K63-linked chains observed in vitro could be mitigated by other
factors in living cells.
To assess global perturbations in the UBC1-EA yeast strain, we
used another SILAC-based proteomics approach (Fig 7D). 4364
unique proteins were identified in this experiment, of which 15 were
less abundant and 29 were enriched in UBC1-EA cells compared
with wild type (Fig 7E, Table EV1). We also recorded the proteomes
after growth at an elevated temperature (37°C) and in a Dubc4 dele-
tion background (Table EV2). In the UBC1-EA strain, significantly
lower amounts of the NAD+-dependent histone deacetylase Hst1
were detected, while various gene products for which Hst1 serves as
a transcriptional repressor (Bedalov et al, 2003) including five Bna
proteins, Sps19, and Tna1 were increased. This indicates a function
of Ubc1-mediated branched ubiquitin chain formation in chromatin
remodeling, which is supported by recent reports of an involvement
of the human homologue Ube2K in this process (Fatima et al, 2020).
We also found that 12 proteins with decreased abundance in the
UBC1-EA strain are associated with cellular stress response path-
ways in the context of DNA replication (Tkach et al, 2012) and
growth at elevated temperatures (M€uhlhofer et al, 2019) (Fig 7D).
Moreover, two key components of the heat shock response, Ssa4
(M€uhlhofer et al, 2019) and Hsp12 (Welker et al, 2010), appeared to
be adversely misregulated, when the UBC1-EA variant was
combined with a deletion of the UBC4 gene (Fig EV4G). Neverthe-
less, it remains unclear at this stage whether the observed change in
abundance of these proteins in the UBC1-EA strain is caused by the
disturbance of a particular cellular pathway or whether the pleio-
tropic functions of Ubc1 are disrupted in multiple processes.
To verify the results of the proteomic analysis, we assessed the
growth of the UBC1-EA strain in the presence of the DNA damaging
agent hydroxyurea (HU) and at an elevated temperature of 37°C
(Fig 7F). Notably, the deletion of the UBC1 gene was shown to
cause a growth defect and to be synthetically lethal with a UBC4
deletion (Seufert et al, 1990; Girard, et al, 2015). Moreover, expres-
sion of Ubc1-DUBA also does not yield viable cells in a Dubc4 back-
ground (Girard et al, 2015). In this context, the UBA domain was
suggested to mediate the recruitment of Ubc1 to the APC/C complex
and to therefore fulfill essential functions during cell cycle progres-
sion. In contrast, the UBC1-EA strain showed normal growth and
produced viable cells in combination with the deletion of the UBC4
gene. However, growth of the Dubc4/UBC1-EA cells was strongly
impaired in the presence of HU and at 37°C. Most likely, the dele-
tion of UBC4 aggravates physiological disruptions caused by
Ubc1-EA due to their partially overlapping cellular functions (Seufert
et al, 1990; Medintz et al, 1998; Hiraishi et al, 2006; Girard et al,
2015). Our data suggest that ubiquitin binding by the UBA domain
and thus branched chain formation by Ubc1 are not essential for
vegetative growth of yeast cells but play an important role in the
maintenance of cellular proteostasis in response to acute stress.
Discussion
Non-covalent ubiquitin-binding interfaces, which coordinate the
positioning of an acceptor ubiquitin (UbA) molecule, have emerged
▸Figure 7. Assembly of K48/K63-branched ubiquitin chains is conserved in S. cerevisiae. Yeast cells harboring ubiquitin-binding-deficient Ubc1 display specificproteomic alterations and are sensitized to stress conditions.
A A flowchart showing the sample preparation for the SILAC-based relative quantification of K48/K63-branched ubiquitin chains from yeast by mass spectrometry.
10xHis-Ub(R54A) was overexpressed in wild-type cells (wt) and either in cells deleted for UBC1 (Dubc1) or cells expressing ubiquitin-binding-deficient Ubc1-EA. The
R54A substitution in ubiquitin enables the production of a marker peptide for K48/K63-branched ubiquitin by trypsin digest, which can be detected by targeted
proteomics (PRM).
B Log2-transformed fold changes of peptides between the Dubc1 strain and wild type were determined. The forward and reverse SILAC experiments are shown on the
x- or y-axis, respectively. The different ubiquitin marker peptides are indicated in the figure. For a list of fold changes, see Fig EV4F.
C Experiment as in (B) but for the UBC1-EA strain and wild type.
D A flowchart depicting the sample preparation for a SILAC-based proteomic shotgun experiment aimed to explore changes in protein abundance in Ubc1-EA-
expressing yeast cells.
E Log2-transformed fold changes of proteins between the UBC1-EA strain and wild type were determined. The forward and reverse SILAC experiments are shown on the
x- or y-axis, respectively. Genes, which were determined to be significantly different in their protein abundance, are marked in red and labeled. Asterisks (*) indicate
genes, which are upregulated at a transcriptional and/or translational level upon heat stress (M€uhlhofer et al, 2019). A double cross (‡) marks genes, for which the
protein product changes in abundance and/or localization in response to DNA replication stress (Tkach et al, 2012).
F Ubc1-EA was genomically integrated into various yeast strains. Exponentially growing cells of the indicated genotype were spotted onto YPD plates in serial 10-fold
dilutions. Where noted, cells were incubated at elevated temperature (37°C) or in the presence of hydroxyurea (HU) to induce DNA replication stress.
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as key regulatory factors of ubiquitin chain synthesis. In this
study, we demonstrate through enzymatic activity assays that the
ubiquitin-associated (UBA) domains of Ubc1 and Ube2K facilitate
the rapid modification of K63-linked polyubiquitin to form K48/
K63-branched chains—a thus far little-studied ubiquitin species.
Based on previously reported data, we propose a structural model
of Ubc1 and Ube2K during branched chain formation. Our model
of the complex assembly also explains the selectivity toward K63-
linked chains even over the structurally very similar M1-linked
chains, which we observed for Ubc1. In detail, binding of the
UBA domain to a distal ubiquitin moiety of a K63-linked chain
facilitates the transfer of ubiquitin from the catalytic UBC domain
to K48 of the adjacent proximal ubiquitin moiety. This requires
coordination of the hydrophobic patch in the distal ubiquitin with
the UBA domain via helix a1 and a3, association of UBC domain
and UBA domain, and the alignment of the active site cysteine of
the UBC domain with K48 in the proximal ubiquitin moiety. The
latter interface is stabilized through interactions of polar side
chains in Ub (D58-N60) and the UBC domain (S81/T84/D123 in
Ubc1 and S85/T88/D127 in Ube2K; Rodrigo-Brenni et al, 2010;
Middleton & Day, 2015).
Although the order of events during the formation of these inter-
actions is unclear, we propose that an extension of the binding inter-
face with UbA increases the dwell time of the enzyme at the
substrate in an appropriate orientation and therefore enhances the
likelihood for the transfer of the donor ubiquitin molecule. Alterna-
tively, one could speculate that the backside binding of the UBA
domain allosterically activates the UBC domain and that the two
domains are drawn together through interaction with a K63-linked
chain. Due to its low binding affinity, Ubc1, similar to the K48-
linked chain elongating system Ubc7/Cue1, presumably associates
with preexisting polyubiquitin conformations instead of inducing
conformational remodeling (Kniss et al, 2018). The high KD value of
~0.2 mM observed for the interaction of the UBA domain with UbA
supports the idea that, in general, the dynamics of ubiquitin chain
building systems rely on very transient binding events with UbA.
Despite this low binding affinity, the UBA domains of Ubc1 and
Ube2K appear to sufficiently stabilize the substrate interaction to
counteract the inherently low reaction rates of Ubc1 and Ube2K,
which we observed in comparison with other chain building E2
enzymes (Ubc7/Cue1 and Ubc13/Uev1a). Ubc1 and Ube2K may be
less active yet more selective, because they contain glutamine as a
so-called gateway residue close to the active site (Q122 and Q126,
respectively). In contrast, other E2 enzymes typically harbor a
leucine or alanine residue at this position (Valimberti et al, 2015;
Rout et al, 2018). Glutamine as gateway residue has been proposed
to form a critical interaction with Y59 in ubiquitin, which regulates
the activity and selectivity of the ubiquitin transfer (Middleton &
Day, 2015). In our experiments, we did not find evidence for a stim-
ulating role of the UBA domain in de novo chain synthesis and in
processive extension of homotypic K48-linked chains. The poor
performance of Ubc1 in these functions supports the specificity for
branched chain synthesis. Indeed, Ub K48 contributes to UBA
domain binding, which may not only block the enzymatic acceptor
site, but also interfere with the interaction of Ubc1 with proximal
ubiquitin moieties in K48-linked chains. Consequently, this mode of
binding should interfere with the recruitment and extension of
K48-linked chains. We conclude that cellular pathways requiring
the processive extension of K48-linked chains by Ubc1 or Ube2K
should not involve the binding of the acceptor ubiquitin by the
UBA domain.
Our work demonstrates that the formation of K48/K63-
branched chains is conserved even in lower eukaryotes such as
S. cerevisiae. At least one of only eleven E2 enzymes in this
organism plays a designated role in their assembly. These obser-
vations underscore the biological significance of this little-studied
protein modification for fundamental cell biological processes. In
higher eukaryotes, K48/K63-branched chains appear to provide
superior resistance against specific deubiquitinating enzymes
compared with homotypic K63-linked chains in the context of
NF-kB signaling (Ohtake et al, 2016). Moreover, K48/K63-
branched chains have been associated with proteasomal degrada-
tion of substrates, which are initially decorated with K63-linked
chains (Ohtake et al, 2018). Our genetic experiments in yeast link
the UBA domain of Ubc1 and hence the generation of K48/K63-
branched ubiquitin molecules to the maintenance of cellular
proteostasis. Furthermore, our data indicate that Ubc4 should be
involved in the formation of K63-linked chains as precursors for
the branching activity of Ubc1. This could occur either directly
through its ability to form short ubiquitin chains of various link-
age types (Rodrigo-Brenni & Morgan, 2007) or through the inter-
action with a K63-specific E3 ligase (e.g., Rsp5; Stoll et al, 2011).
Results of this study will pave the way for the identification of
specific binders and substrates of K48/K63-branched ubiquitin, as
well as for the exploration of conditions that induce their acute
formation. Ultimately, such work will unravel the precise function
of K48/K63-branched chain formation by Ubc1 and Ube2K in the
living cell.
Materials and Methods
Model building and analysis
The structural model of Ube2K in complex with ubiquitin (Fig 1B)
was created using UCSF chimera. A crystal structure of Ube2K,
which contains UBC domain, UBA domain, and UbA-dist (PDB:
6IF1), served as initial framework. Other crystal structures of Ube2K
(PDB: 5DFL, 3E46, 3F92, 3K9P) and crystal structures of different
UBA domains in complex with ubiquitin (PDB: 2QHO, 4UN2) were
superimposed onto 6IF1 to verify the validity of the interdomain
interfaces. UbA-prox was added to the model according to a previ-
ously reported UBC domain/UbA-prox interface determined by
HADDOCK modeling (Middleton & Day, 2015). Distances between
key residues within the model were measured for various protein
conformations using USCF chimera (Fig 1F). The UBC domain/UBA
domain interface was modeled for Ubc1 with the Phyre2 web portal
using the FASTA sequence of Ubc1 and a Ube2K crystal structure
(PDB: 1YLA; Kelley et al, 2015). The UBC domain and UBA domain
of a Ubc1 NMR structure (PDB: 1TTE) were individually superim-
posed onto the resulting complex (Fig 1C–E). The SpotOn web
server (Melo et al, 2016; Moreira et al, 2017) was used to predict
hot spot and contributing amino acid side chains of the UBC
domain/UBA domain interface (Fig 1E). The amino acid sequence
of Ubc1 was aligned with other E2 enzymes (Fig 3A) using Clustal
Omega (Madeira et al, 2019).
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Cloning and mutagenesis
Plasmids used in this study are listed in Table S1. A Ubc1 vector for
recombinant expression in E. coli was generated by amplifying yeast
genomic DNA and cloning into pGex6p1 via BamHI and SalI restric-
tion sites. Point mutations were introduced into vectors using the
QuikChange site-directed mutagenesis kit (Agilent Technologies)
following the manufacturer’s instructions. The identity of all plas-
mids was verified by sequencing.
Yeast strains
To establish the detection of K48/K63-branched chains, the yeast
strain sub328 (genotype: ubil-D1::TRP1 ubi2-D2::URA3 ubi3Dub-2
ubi4-D2::LEU2 +[pUB146] +[pUB100]), which harbors a single ubi-
quitin gene on plasmid pUB146, was modified (Spence et al, 1995).
pUB146 was replaced with either pLP048 (expression of 10xHis-Ub-
R54A) or pLP105 (expression of 10xHis-Ub-R54A,K63R) through
negative selection on 5-Fluorouracil. All other yeast strains were
haploid decedents of DF5 (genotype: MATa/alpha trp1-1[am]/trp1-1
[am] his3-D200/his3-D200 ura3-52/ura3-52 lys2-801/lys2-801 leu2-3,-
112/ leu2-3,-112) that were generated following standard protocols
(Longtine et al, 1998; Gueldener, 2002). Successful genetic modifi-
cations were validated by analytical PCRs and sequencing, as well
as by SDS–PAGE and immunoblotting.
Recombinant protein purification
For heterologous protein expression, BL21 Rosetta cells were trans-
formed with the desired expression plasmids (Table S1). Bacteria
were grown at 37°C until OD600 of 1.0, cooled to 18°C, induced
with 0.5 mM IPTG, and incubated overnight. Cells were pelleted,
resuspended in lysis buffer (see below), and homogenized using the
Avestin EmulsiFlex-C5 homogenizer. Lysate was cleared by centrifu-
gation at 20,000 g at 4°C for 20 min. For GST-tagged proteins, lysis
buffer was GST-buffer (50 mM Tris–HCl, pH 7.5, 200 mM NaCl,
5 mM DTT) with 1 mM PMSF. GST-tagged proteins were precipi-
tated from cleared lysate using Glutathione SepharoseTM 4 Fast Flow
(GE Healthcare). The resin was washed with GST-buffer, and
proteins were eluted with GST-buffer containing 20 mM reduced
glutathione. Alternatively, proteins were released from the resin by
digest with self-made GST-tagged 3C protease overnight. Lysis
buffer for 6xHis-tagged proteins was either 1× PBS (137 mM NaCl,
2.7 mM KCl, 10.1 mM Na2HPO4, and 1.8 mM KH2PO4, pH 7.5) with
1 mM PMSF or 2× PBS with 2 mM 2-mercaptoethanol and 1 mM
PMSF for hUbe1. Proteins with a 6xHis-tag were purified from
cleared lysate using a HiTrap Talon affinity column (GE Healthcare).
After binding, the resin was washed with 5–10 column volumes of
PBS. Proteins were eluted with PBS containing 300 mM imidazole.
The purification of untagged ubiquitin monomers was performed by
acidic precipitation (Michel et al, 2018). 70% perchloric acid was
added dropwise while stirring to the cleared lysate until a total final
concentration of 0.7% was reached. The precipitate was cleared by
centrifugation (20,000 g for 20 min at 4°C). The supernatant was
recovered, and 10 M NaOH was titrated to adjust the pH to 7–8. All
proteins were further purified by size-exclusion chromatography.
The purity of all generated proteins was tested by SDS–PAGE and
Coomassie staining.
Fluorescent labeling of ubiquitin
Ub(S20C) was fluorescently labeled using Alexa Fluor 488 C5 Malei-
mide (Invitrogen) or Alexa Fluor 647 C2 Maleimide (Invitrogen).
Thiol groups were reduced with twofold molar excess of TCEP in 1×
PBS for 10 min at RT. The sample was desalted using NAP5
columns and incubated with the fluorescent dye in fourfold molar
excess in 1× PBS for 90 min in the dark. Subsequently, the sample
was desalted twice using NAP5 columns equilibrated in 50 mM
Tris–HCl, pH 8. The sample was concentrated in an Amicon Ultra
concentrator (3K MWCO, Millipore). Final protein concentration
was determined by Lowry assay. Where indicated, fluorescent ubi-
quitin was methylated using formaldehyde and cyanoborohydride
as described elsewhere (Boersema et al, 2009). The reaction was
quenched with ammonia and formic acid. Excess reagents were
removed using Zeba Spin Desalting Columns (Thermo Scientific).
Assembly and purification of ubiquitin chains
Ubiquitin chains with proximal (i.e., C-terminal) hexahistidine-tag
(6xHis) were assembled enzymatically in vitro typically in a total
volume of 3–10 ml. Synthesis of K48-linked chains was performed
with 1 lM E1 (hUbe1), 20 lM Cdc34, 900 µM ubiquitin, and
600 µM 6xHis-Ub in chain synthesis buffer (50 mM Tris–HCl, pH 8,
9 mM MgCl2, 20 mM ATP, 0.9 mM DTT). K63-linked chains were
assembled with 1 lM E1 (Ube1), 8 lM GST-Ubc13, 8 lM GST-
Uev1a, 1.2 mM ubiquitin, and 0.8 mM 6xHis-Ub in chain synthesis
buffer. Synthesis reactions for ubiquitin chain mixes used in the
in vitro binding assay contained 200 µM Alexa 488-labeled 6xHis-
Ub(S20C) and 1.8 mM ubiquitin instead (500 µl reaction volume).
The synthesis reaction for a K48-/K63-branched ubiquitin trimer
used for the generation of a spectral library contained 470 µM
6xHis-Ub(R54A), 515 µM Ub(K48R,K63R), 10 µM Ubc1(K93R),
8 µM GST-Ubc13, and 8 µM Gst-Uev1A in synthesis buffer
(Fig EV3). All ubiquitin chain synthesis reactions were incubated at
37°C for 18 h. 6xHis-tagged chains were separated from the reaction
mix by metal affinity chromatography using Talon resin. After
elution, ubiquitin chain mixes for the in vitro binding assays were
buffer-exchanged to ubiquitin-binding buffer (see below) using Zeba
Spin Desalting Columns (Thermo Scientific). Ubiquitin chains from
other reactions were separated by gel filtration (HiLoad 26/600
Superdex 75 pg, GE Healthcare) in 1× PBS with a low flow rate
(0.3–0.5 ml/min). Fractions containing ubiquitin chains with a
specific length were collected and concentrated using Amicon Ultra
concentrators (Millipore).
In vitro ubiquitin-binding assay
GST-tagged proteins were immobilized on GSH resin and equili-
brated in ubiquitin-binding buffer (50 mM Tris–HCl, pH 7.5,
150 mM NaCl, 1 g/l BSA). Binding of equal amounts of the respec-
tive proteins to the resin was validated by SDS–PAGE and
Coomassie staining. 25 µl GSH resin with immobilized GST-proteins
were incubated with 150 µl of the respective chain mix (25 µM
monoubiquitin equivalent) for 2 h at 4°C on a rotating wheel. After
the binding step, the samples were centrifuged at 800 g for 1 min,
and the supernatant was collected. The resin was then washed two
times with ubiquitin-binding buffer. Urea sample buffer (8 M urea,
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200 mM Tris–HCl, pH 6.8, 5% SDS, 0.1 mM EDTA, 0.03% (w/v)
bromophenol blue, 50 mM DTT) was added to the supernatant and
to the washed resin, respectively. Samples were heated to 35°C for
5 min and analyzed by SDS–PAGE and fluorescence scan.
In vitro ubiquitination experiments
Single turnover ubiquitination reactions contained 10 µM acceptor
ubiquitin as indicated, 1 µM Alexa 488-labeled monoubiquitin (Ub-
S20C), and 0.2 µM hUbe1 in reaction buffer (50 mM Tris–HCl, pH
7.5, 4 mM MgCl2, 4 mM ATP, and 0.5 mM DTT). Reactions were
started by addition of the respective E2 enzyme (Ubc1 variants/
Ube2K/ubc-20/GST-Ubc13/Ubc7) to a final concentration of 2 µM
together with 2 µM cofactor where indicated (GST-Uev1a/soluble
fragment of Cue1—residues 25-203). In vitro ubiquitination reac-
tions in Fig 6B and C contained 6 µM Alexa 488-labeled monoubi-
quitin (Ub-S20C), 2 µM Alexa 647-labeled K63-Ub3 (proximal Ub
(S20C) with C-terminal 6xHis) and 2 µM full-length Ubc1 or Ubc1-
DUBA in reaction buffer. In vitro ubiquitination reactions in Fig 6D
contained 12 µM Alexa 488-labeled monoubiquitin (Ub-S20C),
3 µM K63-Ub4 (C-terminal 6xHis) and 2 µM full-length Ubc1 or
Ubc1-DUBA in reaction buffer.
At indicated time points, 15 µl samples were removed from the
reaction mixes and added to 15 µl urea sample buffer (8 M urea,
200 mM Tris–HCl, pH 6.8, 5% SDS, 0.1 mM EDTA, 0.03% (w/v)
bromophenol blue, 50 mM DTT). Samples were analyzed by SDS–
PAGE and fluorescence scan using a Typhoon FLA 9500 laser scan-
ner (GE Healthcare). All ubiquitination reactions with Ubc1 were
performed with K93R mutants to block autoubiquitination and thus
autoinhibition (Liess et al, 2019). For kinetic analyses, reactions
were performed in triplicate. Line plots for all lanes in each scan
were extracted using ImageJ. Data were then analyzed by using the
Multipeak Fitting Package in Igor Pro. Peaks were approximated
with Gaussian functions, and linear or constant baselines were auto-
matically determined. Product intensity over total intensity per lane
was plotted over time and approximated with a line function. Initial
reaction rates were determined as slope of the function.
Expression of isotope-labeled ubiquitin for NMR
For the expression of 15N-labeled ubiquitin monomers with and
without 6xHis-tag, cells were grown in minimal medium containing
7.5 g/l Na2HPO4, 3 g/l KH2PO4, 0.5 g/l NaCl, 2 mM MgSO4,
0.1 mM CaCl2, 10 µM FeSO4, 4 g/l glucose, 1 g/l
15NH4Cl, vitamin
mix, and trace element mix. Vitamin mix final concentrations were
1 mg/l D-biotin, 500 µg/l choline chloride, 500 µg/l folic acid,
1 mg/l myoinositol, 500 µg/l nicotinamide, 500 µg/l pantothenic
acid, 500 µg/l pyridoxal hydrochloride, 50 µg/l riboflavin, and
500 µg/l thiamine hydrochloride. Trace element mix final concen-
trations were 50 mg/l EDTA, 8.3 mg/l FeCl3 × 6H2O, 840 µg/l
ZnCl2, 0.13 mg/l CuCl2×2H2O, 100 µg/l CoCl2 × 6H2O, 100 µg/l
H3BO3, and 16 µg/l MnCl2 × 6 H2O.
NMR spectroscopy
K48-Ub2 (0.2 mM) and K63-Ub2 (0.2 mM) carrying either a proxi-
mal or distal 15N-labeled ubiquitin were prepared as described
previously (von Delbr€uck et al, 2016). Diubiquitin was titrated with
unlabeled UBA domain (aa151-215). UBA domain concentrations
ranged from 0 to 1.6 mM. NMR experiments were performed at
298 K in NMR buffer (50 mM Na2HPO4 pH 7,100 mM NaCl, and
5% D2O) and monitored by [15N, 1H]-heteronuclear single quantum
coherence spectroscopy (HSQC) spectra. To determine the KD value
for proximal and distal ubiquitin moieties, a fitting model for two
independent binding sites with different affinities was used (Raasi
et al, 2005). NMR spectra were acquired on Bruker Avance spec-
trometers operating at proton Larmor frequencies ranging from 600
to 950 MHz, equipped with 5-mm 1H{13C/15N} cryogenic probes.
Samples were measured in salt-tolerant NMR tubes in a total
volume of 350–400 µl. Chemical shift referencing was performed
with 4,4-dimethyl-4-silapentane-1-sulfonate (DSS). Spectra were
processed using the TopSpin software provided by Bruker and




A spectral library for K48/K63-branched chains was obtained from
an enzymatically assembled branched ubiquitin trimer (Fig EV3).
The purified ubiquitin trimer was incubated with trypsin in a mass
ratio of 50:1 for an overnight incubation at RT. Peptides were sepa-
rated by reverse-phase chromatography and analyzed on a Q Exac-
tive Plus (Thermo Fisher) with the following settings: MS1: 60,000
resolution; AGC target 3e6; Max IT 10 ms; MS2: 16,000 resolution;
MaxIT 60ms; AGC 4e5. The data were extracted using MQ and
searched against the yeast UniProt database from 2014 plus
version of the additional expected sequences as a result of the
genomic modifications. The data were analyzed with MaxQuant
1.6.3.4 (Cox & Mann, 2008). MaxQuant settings were as follows:
multiplicity 1; fixed modification: carbamidomethyl (C); protease:
trypsin with allowed cleavages after proline; variable modifi-
cations: acetylation (nterm), oxidation (M), and GlyGly (K); PSM
FDR: 0.01; and protein FDR: 0.01. Ubiquitin-related peptides with
the highest score were selected and used as a spectral library for
all subsequent PRM analyses.
Yeast sample preparation for mass spectrometry measurements
To investigate the abundance of K48/K63-branched chains in S. cere-
visiae, yeast strains were transformed with expression plasmids for
10xHis-Ub(R54A) and grown in either unlabeled or Lys8-labeled
minimal media. For the proteomic shotgun experiments, arginine
auxotroph yeast cells (Δarg4::kanMX6) were grown in either unla-
beled or Lys8- and Arg10-labeled minimal media. Equal amounts
of cells (400 ml at 0.6 OD600/ml) from different conditions and
with different labels were combined, mixed, and centrifuged.
Pellets of the combined cells were flash-frozen in liquid nitrogen
and stored at 80°C overnight. Pellets used for branched chain
detection were resuspended in denaturing lysis buffer (6 M GdmCl,
100 mM HEPES, pH 7.5, 300 mM NaCl, 10 mM chloroacetamide,
1 mM PMSF) for mechanical lysis with glass beads. Additional
lysis buffer containing Triton X-100 was added to a final concen-
tration of 0.2% Triton X-100 for solubilization at 4°C for 30 min.
The lysate was cleared by centrifugation and incubated with Ni-
NTA resin. After 2.5 h, the resin was washed twice with wash
buffer 1 (8 M urea, 100 mM HEPES, pH7.5, 300 mM NaCl, 0.2%
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Triton X-100, and 10 mM chloroacetamide) and twice with wash
buffer 2 (8 M urea, 100 mM HEPES, pH7.5, 300 mM NaCl, 0.2%
Triton X-100, 0.2% SDS, and 10mM chloroacetamide). Finally,
protein was eluted using elution buffer (8 M urea, 100 mM HEPES,
pH7.5, 300 mM NaCl, 350 mM imidazole, 0.2% Triton X-100, 0.2%
SDS, and 10 mM chloroacetam ide) and subjected to methanol/
chloroform extraction as described elsewhere (Wessel & Fl€ugge,
1984). The protein pellet was resuspended in denaturation buffer
(6 M urea, 2 M thiourea, and 10 mM HEPES, pH 8.0). 0.5 µg LysC
protease was added and incubated for 3 h at RT while shaking. The
sample was diluted with 50 mM ammonium bicarbonate buffer
before adding 0.5 µg trypsin for digest at RT overnight. For the
proteomic shotgun experiments, pellets were resuspended in 500 µl
lysis buffer (50mM ABC, 10mM DTT, protease inhibitor cocktail
EDTA-free, and 1 mM PMSF) for mechanical lysis with glass beads.
After lysis, 1 ml solubilization buffer was added (25 mM ABC,
10 mM DTT, and 4.5% SDS) and samples were boiled at 95°C for
5 min. Lysates were cleared by centrifugation, alkylated with
iodoacetamide, and quenched with DTT. The samples were then
further processed using solid-phase-enhanced sample preparation
(Hughes et al, 2019). In short, hydrophilic paramagnetic beads were
used to recover protein from the lysate and a peptide digest was
performed on-bead using LysC and trypsin. Subsequently, peptides
were dried and resuspended in a high pH buffer A (5 mM ammo-
nium formate, 2% ACN) and subjected to offline high pH reverse-
phase fractionation (Bekker-Jensen et al, 2017) by HPLC (Thermo
Fisher Dionex Ultimate 3000) on a XBridge Peptide BEH C18 (130 A,
3.5 µm; 2.1 mm × 250 mm) column (Waters) with a multistep
gradient from 0 to 60% high pH buffer B (5 mM ammonium
formate, 90% ACN) over 96 min. In total, 96 fractions were
collected (1 fraction/min) und automatically pooled into 24 frac-
tions. Subsequently, 24 fractions (“Ubc1-EA” samples) or 12 pooled
fractions (“heatshock” and “Dubc4” samples) were subjected for
measurement by mass spectrometry.
Mass spectrometry measurements and settings
For the targeted proteomic measurements, peptides were separated
by reverse-phase chromatography on an effective 80 min gradient
(0, 10, 60, 70, and 80 min with 0, 4, 20, 30, and 50% of 90%
acetonitrile) and analyzed on a Q Exactive HFx (Thermo Fisher) in
positive polarity mode. The PRM settings were as follows: 30k reso-
lution; 2e5 AGC target; 1.6 m/z isolation window; and 100 ms max
ion injection time. In addition, a Top-2 method was integrated into
the same run with the following settings: MS1: 15k resolution; AGC
target: 3e6; Max IT: 10 ms; MS2: 7 500 resolution; AGC target: 1e5;
MaxIT: 12 ms; isolation window: 1.3 m/z; minimum AGC target:
1e4; dynamic exclusion: 30 s; and nCE = 26.
Shotgun proteomic measurements were separated by reverse-
phase chromatography on an effective 21 min (“Ubc1-EA”) or
35 min (“heatshock” and “Dubc4”) gradient. “Ubc1-EA” samples
were analyzed on a Thermo Fisher Q Exactive HFx instrument in
positive polarity mode with the following additional settings: MS1:
60k resolution; AGC target: 2e5; MaxIT: 50 ms; MS2: Top20; 15k
resolution; AGC target: 2e5; nCE = 26; MaxIT: 40ms; isolation
window: 1.3 m/z; minimum AGC target: 1e4; dynamic exclusion:
30 s. Heatshock and Dubc4 samples were analyzed on Thermo-Fisher
Exploris 480 instrument with the following settings: Faims with three
cycle CVs (40,-55, and 70); MS1: 60k resolution; Norm AGC
target: 300%; AGC target = custom; MS2: 15k resolution; normalized
AGC target = 200%; MaxIT = custom; and nCE = 28.
Data analysis of targeted mass spectrometric measurements
Traces of all fragments from precursors in the spectral library were
extracted from all raw files using the Thermo MSFileReader and the
MSFileReader.py bindings written by François Allen. For each scan,
the normalized spectral contrast angle (SCN) was calculated (Toprak
et al, 2014). Peaks were manually selected with an unpublished in-
house PRM-data visualization tool called Vali. Ratios were extracted
from the slope of a linear model on extracted intensity pairs of the
heavy and light channel for each peak across all fragments.
The data were analyzed in parallel with MaxQuant (v.1.6.17.0)
against the UniProt yeast protein sequence database from 2014.
MaxQuant settings were as follows: multiplicity 2 with Lys8 as a
heavy label; fixed modification: carbamidomethyl (C); protease:
trypsin with allowed cleavages after proline; variable modifications:
acetylation (nterm) and oxidation (M); PSM FDR: 0.01; protein FDR:
0.01. Unnormalized peptide ratios as reported by MaxQuant were
read in and log2-transformed distributions were centered to the
median. The corresponding shifts were subsequently applied on
calculated ratios from the PRM measurements. The shotgun and
PRM log2-transformed ratios were visualized together using the
ggplot2 packages in R (3.6.3).
Data analysis of shotgun mass spectrometric measurements
Rawfiles acquired with Faims were converted to CV-specific mzxml
files (Hebert et al, 2018). All Rawfiles or mzxml files were analyzed
in MaxQuant v.1.6.17.0 with the following additional settings: multi-
plicity 2, Lys8 and Arg10 as heavy label; trypsin/P; carbamidomethy-
lation (C) as fixed modification; oxidation (M), acetyl (protein
n-terminal), and deamidation (NQ) as variable modifications; match
between runs enabled; and re-Quantify enabled. P-values were calcu-
lated from reverse and forward experiments using the Significance B
approach (Cox & Mann, 2008). Genes were considered as signifi-
cantly different in their protein log2-fold-changes if they had a
P-value < 0.01 and showed the same fold-change trend in both experi-
ments. These data were then further analyzed using YeastMine
(Balakrishnan et al, 2012).
Data availability
The mass spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium via the PRIDE (Perez-Riverol et al,
2019) partner repository [http://www.proteomexchange.org/] with
the dataset identifiers PXD018651 and PXD022621. A PDB file
containing the model of Ube2K in complex with ubiquitin is avail-
able from the authors upon request.
Expanded View for this article is available online.
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